Concordant and discordant regulation of target genes by miR-31 and its isoforms. by Chan, Yu-Tzu et al.
UC San Diego
UC San Diego Previously Published Works
Title
Concordant and discordant regulation of target genes by miR-31 and its isoforms.
Permalink
https://escholarship.org/uc/item/43p209p5
Journal
PloS one, 8(3)
ISSN
1932-6203
Authors
Chan, Yu-Tzu
Lin, You-Chin
Lin, Ruey-Jen
et al.
Publication Date
2013
DOI
10.1371/journal.pone.0058169
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
Concordant and Discordant Regulation of Target Genes
by miR-31 and Its Isoforms
Yu-Tzu Chan1,2, You-Chin Lin2, Ruey-Jen Lin2, Huan-Hsien Kuo2, Wai-Cheng Thang2, Kuo-Ping Chiu2,
Alice L. Yu2,3*
1 Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taipei, Taiwan, 2Genomics Research Center, Academia Sinica, Taipei, Taiwan,
3Department of Pediatrics/Hematology-Oncology, University of California San Diego Medical Center, San Diego, California, United States of America
Abstract
It has been shown that imprecise cleavage of a primary or precursor RNA by Drosha or Dicer, respectively, may yield a group
of microRNA (miRNA) variants designated as ‘‘isomiR’’. Variations in the relative abundance of isoforms for a given miRNA
among different species and different cell types beg the question whether these isomiRs might regulate target genes
differentially. We compared the capacity of three miR-31 isoforms (miR-31-H, miR-31-P, and miR-31-M), which differ only
slightly in their 59- and/or 39-end sequences, to regulate several known targets and a predicted target, Dicer. Notably, we
found isomiR-31s displayed concordant and discordant regulation of 6 known target genes. Furthermore, we validated a
predicted target gene, Dicer, to be a novel target of miR-31 but only miR-31-P could directly repress Dicer expression in
both MCF-7 breast cancer cells and A549 lung cancer cells, resulting in their enhanced sensitivity to cisplatin, a known
attribute of Dicer knockdown. This was further supported by reporter assay using full length 39-untranslated region (UTR) of
Dicer. Our findings not only revealed Dicer to be a direct target of miR-31, but also demonstrated that isomiRs displayed
similar and disparate regulation of target genes in cell-based systems. Coupled with the variations in the distribution of
isomiRs among different cells or conditions, our findings support the possibility of fine-tuning gene expression by miRNAs.
Citation: Chan Y-T, Lin Y-C, Lin R-J, Kuo H-H, Thang W-C, et al. (2013) Concordant and Discordant Regulation of Target Genes by miR-31 and Its Isoforms. PLoS
ONE 8(3): e58169. doi:10.1371/journal.pone.0058169
Editor: Ramiro Garzon, The Ohio State University, United States of America
Received October 24, 2012; Accepted January 30, 2013; Published March 5, 2013
Copyright:  2013 Chan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by Academia Sinica and grant 98-2320-B-001-001- (2009) from National Science Council of Taiwan. The funders had no
role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ayu@gate.sinica.edu.tw
Introduction
MicroRNAs (miRNAs) are a group of small non-coding RNAs
containing ,22 nt which are involved in many biological
processes of normal and malignant cells [1–4]. During the
traditional biogenesis of miRNA, the primary miRNA (pri-
miRNA) is processed by Drosha and its cofactor Pasha to a ,70
nt stem-loop-like precursor miRNA (pre-miRNA) in the nucleus.
Upon exporting to the cytoplasm by Exportin 5, pre-miRNA is
further trimmed by Dicer to the mature miRNA in double strand
form. After unwinding of mature miRNA duplex, the guide strand
is loaded into the RNA-induced silencing complex (RISC) through
complementary pairing with the target site on the 39-untranslated
region (UTR) of target mRNAs to trigger either translational
repression or mRNA degradation in mammalian system [5–7].
Several lines of evidence have shown that the expression of key
proteins, including Drosha or Dicer, correlated with tumorigenesis
and prognosis in a variety of cancers [8–12]. Although Dicer plays
an important role in miRNA maturation and is implicated in
several biological processes [13–15], the regulation of Dicer has
proved to be complex. It has been shown that Dicer was regulated
by miRNA let-7 and miR-103/107 family [16], which constitutes a
negative feedback loop [17,18].
So far, over 1,500 human miRNAs have been identified and
annotated in the miRBase (version 18.0) [19]. The use of large-
scale deep sequencing technique further uncovered a group of
miRNAs, which diverge from their miRBase annotated sequence
at 59- and/or 39-ends, in both animals and plants [20–27].
Theoretically, isoforms of a specific miRNA could be generated by
imprecise Drosha/Dicer cleavage of a pri-miRNA/pre-miRNA,
leading to miRNAs sequences which match precisely to genomic
sequence. Alternatively, isomiRs could be produced by enzymatic
RNA editing or nucleotide extensions, yielding miRNAs with
sequences matched to genome at every nucleotide except 39-end.
All of these miRNA variants are referred to as ‘‘isomiR"
[23,28,29]. A review of literature and data mining of the reported
sequencing studies have revealed that: (1) The most abundant
isoform of miRNAs may differ from the current miRBase
annotated sequence. For example, the major form of miR-142-
5p in Argonaute (AGO)-IP product from Jurkat cells contains two
additional C at the 59-end, but lacks U at the 39-end as compared
to the miRBase annotated sequence [22,30] (Figure S1A). (2) The
expression pattern of isomiRs across Drosophila melanogaster devel-
opment and tissues varies significantly [31]. (3) Even within the
same cells, such as human umbilical vein endothelial cells
(HUVEC), the most prevalent isoform of miRNAs may differ
under normal and hypoxia stress (e.g. miR-30b-5p and miR-455-
3p in Figure S1B) [32]. Such observation implies that the
population of isomiRs may vary in different types of tissues/cells
or environmental conditions and the submitted sequences in the
miRBase may not be representative for all tissues and cells in a
given species. Moreover, the 59-end variations may result in
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isomiRs of the same miRNA bearing different seed sequence (2nd
to 8th nt), which is the key target recognition element, leading to
their differential regulation of target mRNAs. However, very few
studies have tackled the issue whether these isomiRs with
variations at 59- and/or 39-ends display identical functions. Using
an acellular in vitro target RNA cleavage assay, Azuma-Mukai
et al. demonstrated a difference in target cleavage ability between
miR-142-5p and its variant which contained two extra nucleotides
at the 59-end [22]. In another study, cells were transfected with
biotinylated miR-10a, miR-10b and their isomiRs to pull down
bound mRNAs. Microarray analysis revealed that among hun-
dreds of mRNA enriched in the miRNA pull-down, most mRNAs
were common to their isomiR pull-downs, but some were unique
to the specific isomiRs [33]. Thus, it’s possible that isomiRs may
share certain common mRNA targets but not all mRNA targets.
In this study, we investigated miR-31 isoforms to further address
the issue of their target specificity and the biological functions at
the cellular level.
Results
Variations in the Preponderance of miR-31 Isoforms in
Different Type of Cells
Comparing the reported miR-31 isoform sequences in hES/
hEB [23,32], we noticed that the most abundant isoforms of miR-
31 differed from the miRBase annotated sequence. In addition,
subtle differences in isomiR-31s distribution were observed in
HUVEC cells when cultured under hypoxia and normoxic
conditions, resulting in a change of the major isoform of miR-31
(Figure 1 and Figure S1). We then analyzed the isoforms of miR-
31 in MCF-7 breast cancer cells, HCT116 colon cancer cells, and
LNCaP prostate cancer cells by deep sequencing and compared
them with the reported isomiR-31s culled from the supplementary
data of Morin et al. [23,32]. As shown in Figure 1, the relative
abundance of miR-31 isoforms varied among these cells and the
most abundant isoform of miR-31 differed between hES/hEB/
LNCaP cells and MCF-7/HCT116 cells. We focused on three
isomiR-31s in human cells, annotated in miRBase (version 18.0) as
the major miR-31 in 3 species, hsa-miR-31, ptr-miR-31, and
mmu-miR-31 and dubbed them miR-31-H, miR-31-P and miR-
31-M, respectively. Although these three isomiRs differed only
slightly at 59- and 39-end sequences (Figure 2A), their preponder-
ance varied among different types of human cells (Figure 1).
IsomiR-31s Display Concordant and Discordant
Regulation of Target Genes
To compare the specificity of isomiR-31s on target regulation,
we first examined the effects of transfecting cells with the synthetic
oligos of these isomiR-31s on 6 known targets of miR-31 in MDA-
MB-231 and MCF-7 breast cancer cells which expressed very little
endogenous miR-31 (Figure S2A). These known targets included
CEBPa, STK40, and E2F2 which had been shown to be
downregulated at mRNA level by miR-31-H in ovarian cancer
cells [34] and Frizzled3 (Fzd3) and MMP16 which were repressed
at the protein level by miR-31 in MDA-MB-231 breast cancer
cells [35]. Analysis of the effects of transfecting MDA-MB-231
(Figure 2B) and MCF-7 (Figure 2C) breast cancer cells with
isomiR-31s showed a greater repression of STK40 mRNA
expression by miR-31-H and miR-31-M to about 22% and 50%
of control for MDA-MB-231 and MCF-7 cells, respectively, than
by miR-31-P (to 75% and 95% of control in MDA-MB-231 and
MCF-7 cells, respectively). E2F2 was also more downregulated by
miR-31-H and miR-31-M than by miR-31-P in MDA-MB-231
cells, but inhibited slightly to similar degree by all 3 isomiR-31s in
MCF-7 cells. On the other hand, CEBPa was not significantly
(P.0.05) downregulated by isomiR-31s in MCF-7 cells, but
inhibited to similar degree of control by isomiR-31s in MDA-MB-
231 cells (69%, 65% and 75% of control by miR-31-H, -P, and –
M, respectively; P,0.05). Furthermore, transfection of a cell line
expressing endogenous isomiR-31s, HCT116 colon cancer cells,
revealed that only miR-31-M, but not –H nor –P could
significantly repress these 3 target genes (Figure 2D), implying
cell type specific regulation of target genes by isomiR-31s. The
protein expression of these 3 known targets was also evaluated in
isomiR-31s transfected cells. The results showed that the
regulation of these 3 known targets by isomiR-31s at mRNA
and protein levels was concordant in most but not all cases in
MDA-MB-231 (Figure S3A), MCF-7 (Figure S3B), and HCT116
cells (Figure S3C). We also determined the protein expression of 3
other known targets, Fzd3, MMP16, and MCM2 in MDA-MB-
231 cells transfected with isomiR-31s. As shown in Figure 2E-G,
miR-31-H and –M, but not miR-31-P significantly repressed the
expression of Fzd3, MMP16 and MCM2 [36] and the extent of
inhibition by miR-31-H and miR-31-M was similar for most of
these targets, except that MCM2 was more repressed by miR-31-
H than by miR-31-M. These findings indicated that miRNA
isoforms exerted different degree of repression of verified target
gene of miR-31, even though they possessed identical seed
sequence. It is likely that mechanisms in addition to the base-
paring of seed region could affect target genes repression by
isomiRs (see Discussion). Besides, the inhibitory effects of miR-31-
P on most of the above targets were much less than miR-31-H/
2M. Hence, these findings provided evidence that isomiR-31s
may share identical targets, but also display discriminative
regulatory effects on target genes, which may vary in different
type of cells.
IsomiR-31s Differentially Regulate Dicer Expression
Since isomiR-31s displayed differential regulation of some of the
known target genes, we sought for novel target of miR-31 to
determine if it is differentially regulated by isomiR-31s. Surveying
the prediction websites, PicTar [37] and TargetScan [38], we
found Dicer to be one of predicted candidates. Although Dicer was
reported to be a target gene of miRNA let-7 and miR-103/107
family, we suspected that the regulation of Dicer could be much
more complex than the existing evidence.
To pursue the possible regulation of Dicer expression by
isomiR-31s, MCF-7 cells were transfected with miRNA synthetic
oligos, miR-31-H, miR-31-P, or miR-31-M, obtained from the
Ambion (see the Materials and Methods) and the expression of
Dicer protein was determined. Interestingly, only miR-31-P, but
not miR-31-H or miR-31-M, was able to inhibit Dicer expression
(Figure 3A). To confirm our finding, oligos of isomiR-31s
purchased from another source, Dharmacon, were used in a
similar experiment, which confirmed that miR-31-P, but not other
2 isoforms, repressed Dicer expression (Figure 3B). In order to
demonstrate that the differential repression effect is not due to
unequal transfection efficiency, miR-31 expression level was
determined by RT-qPCR, which showed that these three
isomiR-31s were indeed equally overexpressed in the transfected
cells (Figure S2B and S2C). Similar inhibitory effect of miR-31-P
was also observed in MDA-MB-231 breast cancer cells, A549 lung
cancer cells, and HCT116 colon cancer cells The latter two cell
lines displayed significant level of endogenous miR-31 in contrast
to very low level in MCF-7 and MDA-MB-231 (Figure S2A),
suggesting that the inhibition of miR-31-P is not restricted to one
cell-type nor dependent on endogenous miR-31 level (Figure 3C–
E). To ascertain whether miR-31-P repressed Dicer expression at
IsomiR-31s Differentially Regulate Targets
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both mRNA and translational levels, we determined the Dicer
mRNA expression by RT-qPCR. As shown in Figure 3F, miR-31-
P reduced Dicer expression mainly by translational repression, not
by mRNA degradation.
To further support that isomiR-31s differentially repressed
Dicer expression, we performed the reporter assays with full length
(,4,800 nucleotides) 39-UTR of Dicer mRNA which contains
only one miR-31 recognition site, as predicted by TargetScan and
PicTar websites. A mutant reporter was constructed by deleting
the sequences surrounding the predicted seed region based on
RNAhybrid software to ensure complete destruction of the binding
for miR-31. As shown in Figure 4, the full length reporter activity
was indeed significantly repressed by miR-31-P to 62.36 3.5%
(P=0.004) and 576 8.6% of control (P=0.019) in MCF-7
(Figure 4B) and A549 (Figure 4C) cell lines, respectively. On the
other hand, miR-31-P only slightly reduced the mutant reporter
activity to 86.569.6% and 80.964.0% of control in MCF-7 cells
and A549 cells, respectively. These findings indicated that the
predicted target site was a genuine target of miR-31. Of note,
miR-31-H and miR-31-M appear to promote the luciferase
activities of both wild type and mutant reporters, but they had no
significant effects on Dicer expression, at either mRNA or protein
levels (Figure 3). These findings further strengthened the notion
that isomiR-31s can differentially regulate Dicer expression.
MiR-31-P but not miR-31-H or miR-31-M Enhances
Sensitivity of Cancer Cells to Cisplatin
To explore the biological consequence of negative regulation of
Dicer by miR-31-P, we evaluated the possible impact of miR-31-P
transfection on the chemosensitivity of cancer cells, in view of the
report that Dicer knockdown by siRNA in MCF-7 cells enhanced
their sensitivity to cisplatin [39]. After transfection with different
isomiR-31s, the sensitivity of MCF-7 cells to cisplatin was assessed.
As shown in Figure 5A, the sensitivity of miR-31-H and –M
transfected cells to cisplatin was similar to that of cells transfected
with control oligo, but the miR-31-P transfected cells were more
sensitive in a dose-dependent manner (P,0.01 at 20 mM; P,0.05
at 30 mM). Using nonlinear regression analysis to provide the best
fitted sigmoid curves, plotting the percentages of cell survival
against the drug concentrations (Figure 5C) we further confirmed
greater cisplatin sensitivity of miR-31-P transfected cells than
others (P,0.05). Such phenomenon is not restricted to a specific
cell type, since miR-31-P transfection also significantly enhanced
the sensitivity of A549 lung cancer cell line to cisplatin treatment
(P,0.01 at both 10 mM and 15 mM; Figure 5B), which was
supported by nonlinear regression analysis (P,0.01; Figure 5D).
These findings suggest that down-regulation of Dicer by miR-31-P
contributed at least in part to the increased drug sensitivity.
The Binding Capacity of isomiR to AGO Complex Might
not be the Only Critical Element for the Target Gene
Repression
Previous studies indicated that some miRNA variants were
differentially loaded onto AGOs and 59-end nucleotide of small
RNA was critical for its interaction with AGO proteins [40–42],
suggesting the possibility that isomiR-31s which differed in their
target gene predilection may display differential binding capacity
for AGO complex, which is crucial for target repression. To
determine the binding capacity of miR-31 isoform with AGO
Figure 1. The most abundant isoform and the composition of miR-31 populations vary among five human cells. IsomiR-31s in MCF-7,
HCT116, and LNCaP cells was analyzed by deep sequencing and compared to the reported miR-31 isoforms in human embryonic stem cell (hES)/
embryonic body (hEB) culled from the supplementary data of Morin et.al. [23,32]. The miR-31 precursor sequence is shown at the bottom. The
sequences, which is underlined with thick line or marked with *, is the current annotated miR-31 of human in miRBase (version 18.0). The occurrence
of each sequence read is represented as the count shown in number. The percentage of each sequence indicates its occurrence in the whole
population of miR-31 isoforms. In the miR-31 profile of HCT116 cells, most of sequences with counts of less than 10 were omitted from this figure. #,
the data were culled from the report of Morin et al. H, hsa-miR-31; the miR-31-H form. M, mmu-miR-31; the miR-31-M form. P, ptr-miR-31; the miR-31-
P form.
doi:10.1371/journal.pone.0058169.g001
IsomiR-31s Differentially Regulate Targets
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complex, MCF-7 cells were cotransfected with the plasmid
expressing Argonaute2 (AGO2), one of the 3 isomiR-31s oligos,
and miR-132 oligo, which served as an internal control for
normalization since miR-132 was not a predicted regulator of
Dicer and failed to repress Dicer expression by western blot
analysis (Figure S4A). The binding of isomiR-31s and miR-132 to
AGO2 complexes was determined by RNA-CHIP assay and RT-
qPCR. The result of western blot analysis shown in Figure S4B
documented efficient transfection and immunoprecipitation of
AGO2. Comparing the Ct values of bound isomiR-31s and miR-
132 within control-IP samples to those within AGO2-IP samples,
the amounts of miRNAs captured within AGO2-IPs were hundred
folds higher than those in control-IPs (Ct values ranged from 26.58
to 29.88, and 18.72 to 21.00 for control-IP and AGO2-IP,
Figure 2. Concordant and discordant regulation of known target genes by isomiR-31s. The sequences of isomiRs of miR-31. MiR-31-H,
miR-31-P, and miR-31-M represent hsa-miR-31, ptr-miR-31, and mmu-miR-31 in miRBase, respectively (A). CEBPa, STK40, and E2F2 mRNA expression in
MDA-MB-231 cells (B), MCF-7 cells (C), and in HCT116 cells (D) were detected by RT-qPCR after transfection with synthetic oligos of isomiR-31s. The
mRNA level of each gene was normalized to GAPDH mRNA. The normalized mRNA level of Neg-ctrl transfectant was set as 1.0 and then those of
other isomiR-31 transfections were relative to it. The proteins levels of Fzd3 (E), MMP16 (F), and MCM2 (G) were determined in MDA-MB-231 cells
transfected with 100 nM synthetic oligos by immunoblotting. GAPDH protein served as the internal control for normalization. The normalized protein
level of Neg-ctrl transfectant was set as 1.0 for comparison to those of isomiR-31 transfectants. The data represent the average of 3 independent
experiments with standard deviations (*P,0.05; **P,0.01; ***P,0.001, t-test).
doi:10.1371/journal.pone.0058169.g002
IsomiR-31s Differentially Regulate Targets
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respectively), indicating that miRNAs indeed were effectively
bound within functional AGO2 complexes rather than control
vector. After normalization to the internal control miR-132, the
percentage of bound miR-31-P was set as 100%. As shown in
Figure S4C, the bound miR-31-H within AGO2 complexes was
significantly lower than bound miR-31-P (3869%) (P,0.05),
whereas, the bound miR-31-M was not significantly different from
bound miR-31-P (85619%) (P = 0.36), suggesting that the 59-end
nucleotide of isomiRs was not an absolute criterion for AGO
complex loading (see Discussion).
To eliminate the possibility of differential amplification
efficiency of commercially available miR-31-H RT-qPCR probe
for the 3 isomiR-31s, we used synthetic single stranded RNAs
(ssRNAs) with sequences identical to –H, -P, and –M form (ss-H,
ss-P, and ss-M), to mimic the in vitro RT-qPCR analysis. The
amplification efficiency of RT-qPCR probe for each ssRNA form
was determined with serial dilutions of ssRNA inputs. As shown in
Figure S4D, the slope of these 3 qPCR amplification curves were
almost identical (3.75 for ss-H; 3.73 for ss-P; 3.85 for ss-M),
indicating that the amplification efficiency of the miR-31-H RT-
qPCR probe was equally effective for detecting all 3 isomiR-31s.
In other words, the higher amount of miR-31-P and -M detected
in RNA-CHIP assay was indeed contributed by their higher
binding capacity for the AGO complex. Thus, the differential
binding capacity of isomiR-31s with Argonaute (AGO) complex
was one of, but not a crucial element accounting for the disparate
functions of isomiRs.
Figure 3. The isomiRs of miR-31 display differential ability in repressing Dicer expression. Immunoblotting of Dicer in MCF-7 cells
transfected with 100 nM synthetic oligos purchased from Ambion (A) and Dharmacon (B). Immunoblotting of Dicer in MDA-MB-231 cells (C), in A549
cells (D), and in HCT116 (E) transfected with 100 nM synthetic oligos (Ambion). Relative expression of Dicer mRNA in MCF-7 cells transfected with
miRNA synthetic oligos (Ambion) (F). Data were presented as relative expression level to Neg-ctrl transfectant. Neg-ctrl, negative control oligo.
doi:10.1371/journal.pone.0058169.g003
IsomiR-31s Differentially Regulate Targets
PLOS ONE | www.plosone.org 5 March 2013 | Volume 8 | Issue 3 | e58169
Discussion
MiRNAs have emerged as one of the key regulators for gene
expression. Before isomiRs were discovered, the miRNA variants
were usually missed or ignored by traditional miRNA cloning
technique. With the advances in deep sequencing, increasing
numbers of miRNAs and its cognate miRNAs, miRNA-3p, were
found to differ from the currently annotated sequence in miRBase,
and the population of miRNA isoforms varied among different
tissues or cell types [23,43]. However, the possibility of concordant
or discordant regulation of target genes by different isoforms of
miRNAs has not been validated at the cellular level until this
report. In this study, we used miR-31 as a model to demonstrate
that the most abundant isoform of miR-31 and its cognate
miRNA, miR-31-3p, varied in different cells by comparing our
deep sequencing data in MCF-7, HCT116, and LNCaP with the
Figure 4. Full length 39-UTR of Dicer mRNA was differentially repressed by miR-31 isoforms. Full length 39-UTR of human Dicer mRNA
(GenBank accession number NM_030621.3) (Luc-Dicer 39-WT) is schematically represented. [16] The putative target site (marked by the vertical bar)
was predicted by TargetScan. The sequences of full length wild type (WT) and mutant (Del-mt) reporter plasmid were shown in (A). The wild type or
mutant reporter plasmid was cotransfected with either miR-31-H, miR-31-P, miR-31-M, or negative control (Neg-ctrl). The normalized luciferase
activity of reporter transfected with oligo control (Neg-ctrl) was set to 100%, the reporter activity of other miRNA-transfected groups was relative to it.
MiR-31-P repressed the reporter activity of wild type (WT) full length 39-UTR of Dicer mRNA in MCF-7 (B) and A549 (C) cell lines but not the mutant
reporter. The data represent the average of 3 independent experiments with standard deviations (*P,0.05; **P,0.01, t-test).
doi:10.1371/journal.pone.0058169.g004
IsomiR-31s Differentially Regulate Targets
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previous report (hES and hEB) (Figure 1 and Figure S5). We
further investigated the functions of isomiRs at the cellular level
and provided direct evidences that isomiRs are not equal in their
target regulation. Previously, it was reported that hundreds of
mRNA enriched in the miRNA pull-down were common to their
isomiR pull-downs by microarray analysis [33]. However, a close
scrutiny of their data revealed that some mRNA targets were
unique to the specific isomiRs. Such systems analysis, although
powerful, did not offer direct proof for the regulation of a
particular target by specific isomiRs. Herein, our studies have
provided solid evidence for the complexity of target regulation by
isomiRs at the cellular level.
Several inherent challenges in the investigation of isomiRs were
encountered in our study. First, traditional cloning and sequencing
is not ideal for quantifying isomiRs because cloning frequencies
may not truly reflect the isomiR populations. Another technical
limitation of traditional cloning is to accurately delineate 59- or 39-
end sequence information of a specific miRNA (see Figure S6).
Figure 5. MiR-31-P enhanced the sensitivity of cancer cells to cisplatin treatment. IsomiR-31 transfected MCF-7 breast cancer cells (A) and
A549 lung cancer cells (B) were incubated with cisplatin at the indicated concentrations. At 48 h, the numbers of surviving cells were analyzed by
Alamar Blue reagent and the percentages of cell survival were listed. The percentage of surviving cells of each transfected groups treated with DMSO
was set as 100% to calculate the percentages of surviving cells of cisplatin treated cells at the indicated concentration. Comparing to the negative
control transfected cells, miR-31-P enhanced the sensitivity of both cancer cells to cisplatin treatment (*P,0.05; **P,0.01, t-test). The statistical
significance of the differential sensitivity to cisplatin of MCF-7 (C) and A549 (D) cells transfected with various isomiR-31s was further examined by
nonlinear regression analysis (GraphPad Prism software version 5.01). Nonlinear regression analysis was used to provide the best fitted sigmoid
curves by plotting the percentages of cell survival against the drug concentrations (*P,0.05; **P,0.01, ANOVA). The data represent the average of 3
independent experiments with standard deviations.
doi:10.1371/journal.pone.0058169.g005
IsomiR-31s Differentially Regulate Targets
PLOS ONE | www.plosone.org 7 March 2013 | Volume 8 | Issue 3 | e58169
The use of northern blot analysis is not practical for isomiR study
either, since there are no available commercial probes including
LNA detection probe that can guarantee specific distinction of our
three isomiR-31s. Even if miR-31-M and miR-31-H/2P were
distinguishable by northern blotting, it is not possible to separate
miR-31-H and miR-31-P from each other because of their
identical length. Although the TaqMan qPCR probes were widely
used in miRNA studies, we found that the same probe for miR-31-
H could also recognize the other two isoforms (Figure S4D). Thus,
the specificity of the TaqMan probe is not sensitive enough for our
experiments. Hence, deep sequencing is the only reliable approach
to identify the endogenous isomiRs populations in different cells or
tissue. The second challenge is the limited choice of strategies for
overexpressing and silencing specific isomiRs. Since isomiRs were
processed from the same pri-miRNA/pre-miRNA, it will not be
straightforward to identify specific isomiR-31 generated by
transfecting cells with a plasmid bearing pri-miR-31/pre-miR31
sequence, making it difficult to attribute the observed phenotype to
any specific isoform after transfection. Instead, we used synthetic
double stranded miRNA oligos pledged by Ambion and
Dharmacon for transfection into cancer cells to compare the
functions of isomiRs. To further confirming our finding by
silencing a specific isoform of miR-31 is not feasible either, because
of a lack of molecules that are guaranteed to inhibit specific
endogenous miRNA isoform. Thus, to address the functions of
isomiRs in depth, it may be necessary to simultaneously decipher
the expression profile of target genes and the populations of
isomiRs in different types of cells, which awaits future studies.
Since gene regulation mediated by miRNA requires the ternary
interactions among miRNA/AGO/target mRNA, it is possible
that differential interactions of isomiRs within the ternary complex
may lead to disparate regulation of target genes. In this study, the
observed discrepancy between the miR-31 isoforms bound within
AGO-IP and their repression of Dicer and other known target
genes suggested that the affinity of a given miRNA to AGO or
their seed sequences might not be the only critical elements for the
target gene repression. In fact, several factors have been shown to
dictate the recognition of target site by miRNA, such as (1) the
sequence composition of the 39-UTR [44], (2) the immediate
environment of the putative target site [45], (3) the structural
accessibility of the target site [46,47], and so forth. Besides,
endogenous natural antisense transcript (NAT), which was
transcribed from the opposite strand of protein-coding gene or
non-protein coding gene [48], and the RNA binding proteins [49]
could directly bind to mRNA, thereby masking the miRNA
binding site of target gene and preventing the inhibitory effects of
the miRNA on target gene translation. Although the bindings of
miR-31-P and –M to AGO complexes were comparable, the
above-mentioned factors might come into play in the differential
regulation of Dicer and other known target genes expression. The
exact mechanisms underlying the target specificity of isomiRs
await further investigation in the future. Taken together, the
variations in the relative abundance of isomiRs among different
cell types coupled with our finding that isomiRs could differentially
regulate the expression of target genes, suggest that isomiRs may
play a more general and weighty role in nature by fine-tuning
target gene expression.
Materials and Methods
Cell Cultures
MCF-7 breast cancer cell line was cultured in Modified Eagle
Medium supplemented with 10% fetal bovine serum, 10 mg/ml
insulin, 1% Glutamax, and 1% sodium pyruvate. A549 lung
cancer cell line was cultured in RPMI1640 medium supplemented
with 10% fetal bovine serum. MDA-MB-231 breast cancer cell
line was cultured in Dulbecco’s Modified Eagle Medium
supplemented with 10% fetal bovine serum. All cell lines were
obtained from American Type Culture Collection (ATCC,
Manassas, VA).
MiRNA Oligos
For isomiR study, miRNA synthetic oligos were purchased from
Ambion (Austin, TX, USA) and Dharmacon (Lafayette, CO,
USA). All miRNA synthetic oligos from both sources were double
strand form and were guaranteed products by manufacturers. The
miRNA synthetic oligos of hsa-miR-31 were purchased from
Ambion (hsa-miR-31:Cat. #PM11465, ptr-miR-31: Cat.
#PM10757, and mmu-miR-31: Cat. #PM10653) and Dharma-
con (hsa-miR-31: Cat. #C-300507-05, ptr-miR-31:Cat. #C-
120371-00, and mmu-miR-31: Cat. #C-310524-05), and desig-
nated as miR-31-H, miR-31-P, and miR-31-M, respectively. For
RNA-CHIP assay, pre-miR-132 (Ambion, Cat. #PM10166) was
used as an internal control (see the section below).
Plasmids and Luciferase Reporter Assay
The flag-AGO2 plasmid was kindly provided by Dr. S. C. Lu
(National Taiwan University, Taiwan). The full length 39-UTR of
wild type Dicer reporter plasmid (Luc-Dicer 39-WT) was a
generous gift from Dr. Piccolo [16]. The mutant 39-UTR reporter
was generated by using the QuickChange XL Site-Directed
Mutagenesis Kit (Stratagene, La Jolla, CA, USA) with primer
pairs, Del-mt F/Del-mt R, according to the manufacturer’s
instruction. All primer sequences are listed in Table S1. For
reporter assay, 0.2 mg of Luc-Dicer 39-WT or 0.2 mg of mutant
reporter plasmid (Del-mt) was cotransfected with 0.2 mg of phRG-
TK vector (internal control for normalization) and miRNA oligos
(20 nM final concentration) (Ambion) by lipofectamine 2000
(Invitrogen, Carlsbad, CA, USA). Forty-eight hours after trans-
fection, cells were harvested and the luciferase activity was
determined by Dual-Luciferase Reporter Assay System (Promega).
Western Blot Analysis
The western blot analysis was conducted as described previously
[12,50]. Forty microgram of cell lysate of each sample was
separated by 4–12% gradient NuPAGE (Invitrogen). To detect Dicer
and internal control tubulin proteins, the primary antibody to
Dicer was purchased from Abcam Inc. (ab14601; Abcam,
Cambidge, MA, USA), and the antibody to tubulin was purchased
from Sigma (clone B-5-1-2; Sigma, St Louis, MO, USA). The
antibodies for Fzd3 protein and MMP16 protein were purchased
from GeneTex Inc. (GTX100182 and GTX109378, respectively;
GeneTex, San Antonio, TX, USA). The antibodies for detecting
MCM2 protein and the internal control GAPDH protein were
purchased from Epitomics Inc. (2901-1 and 2251-1, respectively;
Epitomics, Burlingame, CA, USA). The signal of protein bands
was revealed by ECF western blotting kit (Amersham Biosciences,
Piscataway, NJ, USA) and measured by Typhoon 9400 imager
(Amersham Biosciences).
RNA-CHIP Assay
Ten microgram of flag-CMV2 or flag-AGO2 plasmid was
cotransfected with 80 nM isomiR-31 oligos (-H, -P, or –M,
individually) as well as 20 nM miR-132 oligos (as an internal
control) into MCF-7 cells. Transfected cells were harvested 72 h
after transfection. Before cells lysis, ,105 cells were collected for
RNA extraction by Trizol (Invitrogen) and designated as ‘‘RNA-
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input part’’. The remaining cells were treated with lysis buffer
(150 mM KCl, 25 mM Tris-HCl (pH 7.4), 5 mM EDTA, 0.5%
NP-40, 5 mM DTT, and 16protease inhibitor) for 30 min and the
cell lysates were separated by centrifugation at 12,000 g for
20 min at 4uC. Forty microgram of cell lysate was collected as
‘‘PROTEIN-input part’’ for the following western blot analysis
with the flag-specific antibody (F3165; Sigma) to confirm the
expression of transfected AGO2 plasmid. Twenty-five microliter of
Protein G Dynabeads (Invitrogen) and 4 mg of flag–specific
antibody were added to 1 mg cell lysate (in a final 1 ml mixture
filled with lysis buffer) and the mixture was rotated for overnight at
4uC. The beads were washed three times with 1 ml lysis buffer to
remove non-specific binding. After washings, the beads were
resuspended in 1 ml lysis buffer and 50 ml (5% of total volume) of
the suspension were collected as ‘‘PROTEIN-IP part’’ for western
blot analysis with the flag-specific antibody (F3165; Sigma) to
confirm the efficiency of AGO2 immunoprecipitation in each
sample. The RNAs bound on the remaining beads were extracted
by Trizol and the RNAs were precipitated with linear acrylamide
(Ambion), which was designated as ‘‘RNA-IP part’’. MiRNA
expression of both INPUT and IP part RNAs were analyzed by
RT-qPCR (as described below). AGO2 proteins of both INPUT
and IP parts were analyzed by the western blot analysis.
RT-qPCR Assay and Analysis
Ten nanogram of total RNA was used for quantification of
miRNAs expression, including isomiR-31s, miR-132 and RNU6B
(U6) RNA, by TaqMan RT-qPCR kit (Assay ID 002279 for all
miR-31 isoforms, Assay ID 000457 for miR-132, and Assay ID
001093 for RNU6B; Applied Biosystems, Foster City, CA, USA)
according to the manufacturer’s instruction. For RNA-CHIP
assay, the normalized miR-31 amount in each IP was calculated as
the DCt ( =CtmiR31– CtmiR132). The amount of bound miR-31-P
in the AGO2/miR-31-P cotransfectant was set as 1.0 and the
relative amount of bound isomiR-31 in AGO2/miR-31-H or
AGO2/miR-31-M cotransfectants was calculated by the formula:
22(DCt of AGO2/miR31H or M 2 DCt of AGO2/miR31P). For the
quantitation of mRNAs of Dicer, CEBPa, STK40, and E2F2,
1 mg of total RNAs were reverse transcribed into cDNA using the
SuperScript III kit (Invitrogen) and the specific mRNAs were
detected by Power SYBR Green PCR Master Mix (Applied
Biosystems) according to the manufacturer’s instruction. The
primer sequences and PCR condition of Dicer qPCR were
performed as described previously [9]. The primers for CEBPa,
STK40, and E2F2 detections were as designed on the OriGene
website (http://www.origene.com/). The RT-qPCR was per-
formed on the 7300 Real-Time PCR System (Applied Biosystems).
MiRNA Deep Sequencing
MiRNA was isolated from the total RNA sample using
mirVanaTM miRNA Isolation Kit (Ambion, AM1561) and
subsequently constructed into fragment sequencing library using
the procedure of SOLiDTM Small RNA Expression Kit (Applied
Biosystems, 4397682). Procedure for fragment sequencing library
construction, including template bead preparation, emulsion PCR,
bead deposition and sequencing by SOLiDTM3 system (Applied
Biosystems), was based on the standard protocol provided by the
company.
Cisplatin Resistance Determination and Alamar Blue
Assay
Cells were transfected with 100 nM synthetic isomiR-31 oligos
(Ambion). Seventy-two hours after transfection, cells were
incubated with indicated concentrations of cisplatin (Sigma) for
48 h. Cell viability was analyzed by Alamar Blue reagent
(Biosource International, Camarillo, CA, USA) according to the
manufacturer’s instruction. The percentage of surviving cells of
each transfected groups treated with DMSO was set as 100% to
calculate the percentages of surviving cells of cisplatin treated
groups at the indicated concentration by the following formula:
(the OD590 value in drug group/the OD value in DMSO solvent
control group)6100%, respectively. To further assess the statistical
significance of differential cisplatin sensitivity of cells transfected
with various isomiR-31s, the nonlinear regression model and the
classic equation of ‘‘sigmoid dose-response (variable slope)’’ were
chosen, and then the sigmoid concentration response curves were
generated using GraphPad Prism software version 5.01 (Graph-
Pad, La Jolla, CA, USA). Before fitting the dose-response curves,
the parameter of logEC50 was selected for asking the significant
difference among each data set. Moreover, the top and bottom of
best-fit values were constrained as 100 and 0 for fitting the top and
bottom plateau of the curves. The statistical significance of best
fitted curves between miR-31-P transfected cells and other groups
was determined.
Supporting Information
Figure S1 The sequences of most abundant isoforms of
miRNAs differ among various cells and type of culture
conditions within the same cell. (A) Based on the report of
Azuma-Mukai et al., the sequence of the most abundant form of
miR-142-5p in Jurkat cells differs from the miRBase annotation
(version 18.0) in 59- and 39-end [22,30]. Our deep sequencing data
in MCF-7, HCT116 and LNCaP cell lines showed that the most
abundant forms of miR-31 in hES/hEB/LNCaP are different
from that in MCF-7/HCT116. The latter is identical to the
miRBase annotated sequence (version 18.0) [23,30]. The most
abundant isoforms of miR-151-5p differ in Jurkat and hES/hEB
cells and both of which differ from miRBase annotation
[22,23,30]. (B) The most abundant isoform of miR-30b-5p,
miR-455-3p, and miR-31 in HUVEC cells differs under hypoxia
and normal culture condition [32]. The isoforms sequence
mismatching to precursor sequence due to SNPs or editing-events
were excluded from this table.
(TIF)
Figure S2 The expression levels of miR-31 as detected
by RT-qPCR. The expression levels of endogenous miR-31 in
MCF-7, MDA-MB-231, A549, and HCT116 cancer cells (A). The
level of overexpressed isomiR-31s in MCF-7 cells transfected with
synthetic oligos from Ambion (B) and Dharmacon (C). The
expression level was shown as miR-31 (2DCt), which is equal to –
(CtmiR-312CtU6).
(TIF)
Figure S3 The regulation of 3 known targets including
CEBPa, STK40, and E2F2 by isomiR-31s at protein levels
in MDA-MB-231 (A), MCF-7 (B), and HCT116 (C) cell
lines. GAPDH or tubulin protein served as the internal control
for normalization. The normalized protein level of Neg-ctrl
transfectant was set as 1.0 for comparison to those of isomiR-31
transfectants.
(TIF)
Figure S4 IsomiRs have differential binding abilities to
the AGO complex. (A) Immunoblotting of Dicer in MCF-7 cells
transfected with Negative control (Neg-ctrl) or miR-132 oligo.
Tubulin protein served as the internal control for normalization.
(B) The transfection condition was as indicated in the upper panel.
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The transfection and immunoprecipitation procedures were
confirmed by the western blotting. Forty microgram of total cell
lysate of each sample before IP procedure was used as the input
control and 5% of the IP product was used as the IP control for the
following western blot analysis. Flag-AGO2 protein was detected
by the flag–specific antibody. (C) The relative amounts of bound
miR-31 isoforms in AGO2-IP products. The bound miR-31
isoform was detected by RT-qPCR assay. After normalizing to the
miR-132 internal control, the amount of bound miR-31-P was set
as 100% and the others were relative to it. The data represent the
average of 3 independent experiments with standard deviations
(*P,0.05, t-test). (D) The miR-31 RT-qPCR probes for detecting
of miR-31 isoforms have similar amplification efficiencies.
Synthetic single strand RNAs with sequences corresponding to
miR-31-H, miR-31-P, and miR-31-M were denoted as ss-H, ss-P,
and ss-M, respectively. X-axis indicated the concentration of single
strand RNA input, y-axis indicated the Ct value of RT-qPCR
detection. The regression line of qPCR amplification for each
ssRNA template was calculated and shown. The amplification
efficiency of RT-qPCR probe for each ssRNA form was
determined with the serial dilutions of ssRNA inputs and is shown
as the regression line. The slope of these 3 qPCR amplification
lines were almost identical (3.75 for ss-H; 3.73 for ss-P; 3.85 for ss-
M), indicating that the amplification efficiency of this RT-qPCR
probe was fairly similar for the detection of these 3 isomiR-31s.
(TIF)
Figure S5 The differential populations of miR-31-3p
isoforms, the cognate miRNA of miR-31, in human cell
lines. The isoforms of miR-31-3p in MCF-7, HCT116, and
LNCaP cells were identified by deep sequencing. The isomiR-31-
3p information of hES/hEB cells was culled from the supplemen-
tary data of Morin et al. [23]. The sequence underlined with thick
lines or marked with & is the current annotated miR-31-3p of
human in the miRBase (version 18.0). All the most abundant miR-
31-3p sequence of hES/hEB and MCF-7/HCT116 cells are not
identical to the annotated sequence of the miRBase (version 18.0).
The occurrence of each sequence read is represented as the count
shown in number. In HCT116 profile, most of sequences, which
the counts were less than 10, were omitted from this figure. The
percentage of each sequence indicates its occurrence in the whole
population of miR-31-3p isoforms. #, the data were culled from
the report of Morin et al.
(TIF)
Figure S6 The cloning scheme of isomiR-31s were
plotted to show that traditional cloning and sequencing
is not ideal for identifying a specific miRNA isoforms.
The converting procedure of miRNAs/small RNAs into detect-
able cDNA was shown in the upper panel. After the cDNA pool of
small RNAs was generated, isomiR-31s could specific tag and
amplify by (A) 59 primer (the primer sequence was complemented
to 59 adaptor and 59-end of miR-31) and 39 primer (the sequence
was complemented to 39 poly A adaptor), or by (B) 59 primer (the
sequence was complemented to 59 adaptor) and 39 primer (the
sequence was complemented to 39 poly A adaptor and 39-end of
miR-31) from the cDNA library for miR-31 cloning. However,
using primer set A or B would loss the 59-end or 39-end
information of the isomiR-31s, respectively.
(TIF)
Table S1 Primers sequence.
(DOC)
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